Health In Tech, Inc. Class A Common Stock (HIT) — Capital Reinvestment Ratio

Latest as of December 2025: 3.57x

Health In Tech, Inc. Class A Common Stock (HIT) has a Capital Reinvestment Ratio of 3.57x as of December 2025, meaning it reinvests 4% of its operating cash flow ($451.21K) in capital expenditures ($1.61 Million). See Health In Tech, Inc. Class A Common Stoc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

3.57x
Capex / Operating Cash Flow

Operating Cash Flow

$451.21K
USD

Capital Expenditures

$1.61 Million
USD

Data as of

Dec 2025
Most recent filing

Health In Tech, Inc. Class A Common Stock Capital Reinvestment Ratio (2022–2025)

This chart tracks Health In Tech, Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods. Check Health In Tech, Inc. Class A Common Stoc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Health In Tech, Inc. Class A Common Stock (2022–2025)

Year-by-year Capital Reinvestment Ratio for Health In Tech, Inc. Class A Common Stock from 2022 to 2025. For live market cap and broader valuation context, see Health In Tech, Inc. Class A Common Stoc stock valuation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 1.02x $3.13 Million $3.19 Million ▲ +145.9%
2024 0.41x $2.18 Million $900.75K ▼ -44.7%
2023 0.75x $1.53 Million $1.14 Million ▼ -52.0%
2022 1.56x $782.75K $1.22 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow